Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

FNP Review > EENT > Flashcards

EENT Flashcards

1
Q

Most common bacterial pathogen in bacterial sinusitis, acute otitis media, & community acquired pneumonia?

A

Streptococcus pneumoniae (gram + diplococci)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Common pathogen in bacterial rhino sinusitis, comm acquired pneumonia (particularly with tobacco use).

A

H. Influenza (gram - bacillus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Less common pathogen in bacterial rhino sinusitis, uncommon cause of comm acquired pneumonia

A

M. Catarrhalis (gram - coccus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antibiotic resistance risk factors

A 
Age 65
Daycare
Prior abt in the past month
Prior hospitalization w/in the past 5 days
Comorbidities 
Immunocompromised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Symptomatic treatments for bacterial rhino sinusitis

A

Nasal saline irrigation
Intranasal corticosteroids (when accompanying allergic rhinitis)
Topical or systemic decongestant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Treatment of bacterial rhino sinusitis (adults)

A

Duration- 10-14 days
1st line- amox./clavulanate 500/125mg po TID or 875/125mg BID, TMP/SMX (Bactrim), doxycycline

2nd line- amox/clavulanate 2000/125mg BID (? Resistance) or doxycycline 100mg BID or 200mg QD

PCN/ceph. Allergy- doxycycline 100mg BID or 200mg QD, or Levaquin 500mg QD (? Resistance) or Moxifloxacin 400mg QD (? Resistance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CYP450 3A4 substrate

A

Utilizes a specific enzymatic pathway.

Medication that is metabolized by the isoenzyme, utilizing this enzyme in order to be modified so it can reach drug site of action &/or be eliminated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CYP450 3A4 inhibitor

A

Blocks a specific enzymatic pathway, keeps substrate (medication) from exiting (leads to toxicity)

Blocks the activity of the isoenzyme limiting substrate excretion, allowing increase of substrate levels & possible risk of substrate induced toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CYP450 3A4 inducer

A

Pushes the substrate out the exit pathway.

Accelerates the activity of the isoenzyme so that substrate is pushed out the exit pathway, leading to reduction in substrate (medication) level.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Treatments of allergic rhinitis

A
  • Avoidance measures
  • Controller meds (1st line- Intranasal corticosteroids, ex. Flonase, nasocort), add on treatment- singulair.
  • Reliever meds (2nd gen antihistamines- Claritin, Zyrtec), Intranasal antihistamine- asteline, astepro) ocular antihistamine- patanol, pataday.
  • Immunotherapy- ex-Xolair
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Characteristics of eye discharge with allergic conjunctivitis?
Bacterial conjunctivitis?
Viral conjunctivitis?

A

Allergic- ITCHING, stringy, rope like discharge, tearing, mild lid edema, bilateral conjunctival hyperemia.

Bacterial- UNILATERAL, mucopurulent discharge, crusty drainage in eyelids, conjunctival injection/hyperemia

Viral- watery discharge, acute onset, highly contagious, conjunctival hyperemia, edema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical findings in closed-angle glaucoma?

A

A deeply cupped optic disc
Usually unilateral, acutely red, & painful (due to sudden increase in intraocular pressure)
Vision changes including halos around lights.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pt complaints with open-angle glaucoma?

A

Peripheral vision loss (due to gradual onset of increased intraocular pressure leading to optic atrophy)
Avoidable with appropriate, ongoing intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pt complaints with macular degeneration?

Clinical findings?

A

Painless vision changes including distortion of central vision (due to thickening, sclerotic changes in retinal basement membrane complex)
Clinical- Drusen (soft yellow deposits in the macular region) often visible with funduscopic exam.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ophthalmologic test for early detection of Macular degeneration?

A

Amsler grid test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ophthalmologic test for measuring intraocular pressure (test for glaucoma)

A

Tonometry

17
Q

Definition of Anosmia/hyposmia?

A

Diminished sense of smell, with resulting decline in fine taste discrimination (due to neural degeneration)
*accelerated by tobacco use

18
Q

Definition of presbycusis?

A

Difficulty with conversation in noisy environment. Person can hear, but it’s hard to understand what is said (due to loss of 8th CN sensitivity)

19
Q

Treatment of suppurative (purulent) conjunctivitis?

A

1st line- ophthalmic fluroquinolone (levofloxicin, Moxifloxacin)
Alternative- polymixin B with trimethoprim solution or azithromycin 1% ophthalmic solution. Tobramycin 0.3%, gentamicin 0.3% solution.

20
Q

Treatment of otitis externa?

A

Mild- acetic acid with propylene glycol & hydrocortisone gtts.
Moderate to severe- ciprofloxacin with hydrocortisone gtts.

21
Q

Treatment of Malignant otitis externa in pt with DM, HIV, or on chemotherapy? (Invasive form that can lead to osteomyelitis of cartilage/bone)

A

Oral ciprofloxacin for early disease, suitable for outpatient use.
Send to ER or ENT

22
Q

Treatment of exudative pharyngitis?

A

1st line- PCN VK po x10 days, or benzathine Pcn IM x1dose

Alternative- erythromycin x10 days, 2nd generation cephalosporin x4-6 days, azithromycin x5 days

23
Q

Treatment of otitis media?

A

Amoxicillin, azithromycin, augmentin, cefdinir (omnicef), clindamycin for persistent AOM

24
Q

What are nasal polyps?

What conditions are they seen with?

A

Pale, sack-like growths of tissue, that may be inflamed.

May be present with chronic allergic rhinitis, chronic sinusitis, asthma, ASA sensitivity, & cystic fibrosis.

25
Q

Diabetic retinopathy definition?

3 stages?

A 
Damage to the retina caused by complications of Diabetes. 
Stages: 
1. Background DM retinopathy 
2. Pre-proliferative DM retinopathy 
3. Proliferative DM retinopathy
26
Q

Subjective & objective findings with DM retinopathy?

A

Sub- visual changes
Obj- microaneurysms, intra-retinal hemorrhage, macular edema, & lipid deposits.
Nerve layer infractions, COTTON WOOL SPOTS, venous dilation & retinal hemorrhage.

27
Q

Only pharmacological agent found to slow progression of DM retinopathy?

A

ACE inhibitor- Lisinopril

28
Q

Risk factors for Tinnitus?

A

Ménière’s disease, labyrinthitis, HTN, head trauma, thyroid dysfunction.
Meds with reversible effects-salicylate, quinine, indocin, alcohol.
Meds with irreversible effects- streptomycin, gentamicin, vancomycin (aminoglycosides)

29
Q

Management of tinnitus?

A

Avoidance of offending med- (such as ASA, NSAIDS)
Antidepressants may be helpful.
Supplements- (vitamin A, C, B12, nicotinic acid, magnesium or copper).
Tinnitus-masking devices.
Learning to cope with tinnitus is necessary.

30
Q

Temporomandibular Joint Disease TMJ definition & symptoms?

A

A cluster of disorders related to mastication.

Sx- (most common)-pain in the muscles of mastication, preauricular area, & tenporomandibular area.

31
Q

Treatment of TMJ?

A

PT, behavioral therapy.

Meds- NSAIDS, muscle relaxants, antidepressants, topical analgesics.

FNP Review (15 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions